Continuous Glucose Monitoring for Self-Management of Type 2 Diabetes in Young Adults
Recruiting · NCT07065721 · Interventional (participants receive a specific treatment) · Lead sponsor: San Diego State University
View the official record on ClinicalTrials.gov →Interventions studied
Continuous glucose monitor
What this trial is about
Type 2 diabetes in increasing common in young adults. Utilizing a mixed-methods, community-based approach, this study offers continuous glucose monitors (CGMs) to young adults with type 2 diabetes for 30 days, and collects both quantitative and qualitative data to understand barriers and facilitators of CGM use, participants' changes in awareness of glucose patterns while using the CGM, and preferences for a CGM-based self-management intervention.
Who can take part
Age range
18 Years to 45 Years
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- adult 18-45 years of age
- diagnosis of type 2 diabetes in the last 5 years, as evidenced in the electronic medical record
- no prior use or experience with wearable CGMs
- possession of a smart phone that is compatible with Dexcom CGM sensors (nearly all smartphones are compatible) and willing to download and utilize the Dexcom CGM app
- fluency in English or Spanish
Exclusion criteria
- severe mental illness (e.g., psychosis, suicidal ideation);
- pregnancy or \<6 months postpartum
Where it is running
1 location listed across 1 US state.
- Scripps Health - San Diego, California, United States